Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
KYMRKymera Therapeutics | $2.21bn | n/a | n/a |
DCPHDeciphera Pharmaceuticals | $2.20bn | n/a | n/a |
GERNGeron | $2.19bn | n/a | n/a |
NVAXNovavax | $2.08bn | n/a | n/a |
RCKTRocket Pharmaceuticals | $2.07bn | n/a | n/a |
BEAMBeam Therapeutics | $2.04bn | n/a | n/a |
CGONCG Oncology | $1.93bn | n/a | n/a |
AGIOAgios Pharmaceuticals | $1.92bn | n/a | n/a |
SANASana Biotechnology | $1.91bn | n/a | n/a |
KROSKeros Therapeutics | $1.89bn | n/a | n/a |
PTGXProtagonist Therapeutics | $1.83bn | 12.71 | n/a |
FUSNFusion Pharmaceuticals | $1.83bn | n/a | n/a |
ARDXArdelyx | $1.81bn | n/a | n/a |
INBXInhibrx | $1.79bn | n/a | n/a |
NAMSNewAmsterdam Pharma NV | $1.79bn | n/a | n/a |
AMAMAmbrx Biopharma | $1.76bn | n/a | n/a |
SNDXSyndax Pharmaceuticals | $1.72bn | n/a | n/a |
VCYTVeracyte | $1.70bn | n/a | n/a |
KURAKura Oncology | $1.69bn | n/a | n/a |
EWTXEdgewise Therapeutics | $1.67bn | n/a | n/a |